Top

Publications

Picture1.png

2023

  • Dáire Gannon, Eimear Lagan, Ademar Jesus Silva, Peter Bibawi, Anthony M. Doherty, Darragh Nimmo, Rachel McCole, Craig Monger, Giovani Genesi, Aurelie Vanderlinden Dibekeme, James A. Innes, Lu Yang, Bryan Chen, Guido van Mierlo, Pascal W.T.C Jansen, Keiran Wynne, Fran-cisco J. Sánchez-Rivera, Yadira M. Soto-Feliciano, Michiel Vermeulen, Giorgio Oliverio, Chun-Wei Chen, Richard E. Philips, Adrian P. Brackenand, Gerard L. Brien (2023). Specific cPRC1 complexes are co-opted to mediate oncogenic gene repression in diffuse midline glioma. bioRxiv doi: https://doi.org/10.1101/2023.12.02.569451


2022

  • Liang, R., Tomita, D., Sasaki, Y., Ginn, J., Michino, M., Huggins, D. J., Baxt, L., Kargman, S., Shahid, M., Aso, K., Duggan, M., Stamford, A. W., DeStanchina, E., Liverton, N., Meinke, P. T., Foley, M. A., & Phillips, R. E. (2022). A Chemical Strategy toward Novel Brain-Penetrant EZH2 Inhibitors. ACS medicinal chemistry letters, 13(3), 377–387. https://doi.org/10.1021/acsmedchemlett.1c00448


2020

  • Phillips, R. E., Soshnev, A. A., & Allis, C. D. (2020). Epigenomic Reprogramming as a Driver of Malignant Glioma. Cancer cell, 38(5), 647–660. https://doi.org/10.1016/j.ccell.2020.08.008


2019

  • Phillips, R. E., Yang, Y., Smith, R. C., Thompson, B. M., Yamasaki, T., Soto-Feliciano, Y. M., Funato, K., Liang, Y., Garcia-Bermudez, J., Wang, X., Garcia, B. A., Yamasaki, K., McDonald, J. G., Birsoy, K., Tabar, V., & Allis, C. D. (2019). Target identification reveals lanosterol synthase as a vulnerability in glioma. Proceedings of the National Academy of Sciences of the United States of America, 116(16), 7957–7962. https://doi.org/10.1073/pnas.1820989116


2015

  • Phillips, R. E., Curran, K. J., & Khakoo, Y. (2015). Management of late extraneural recurrence of medulloblastoma without high-dose chemotherapy. Journal of neuro-oncology, 124(3), 523–524. https://doi.org/10.1007/s11060-015-1850-x